http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101318031-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-38 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-36 |
| filingDate | 2011-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101318031-B1 |
| titleOfInvention | Pharmaceutical composition for the treatment of inflammatory and autoimmune diseases |
| abstract | The present invention is effective in anti-inflammatory and immunomodulatory activity by inhibiting the expression and production of prostaglandins (PGE 2 ), AP-1 and TNF-α, and is effective in the prevention and improvement of inflammatory and autoimmune diseases. To this end, in particular, a pharmaceutical composition for the prevention and improvement of inflammatory and autoimmune diseases comprising a peptide using modified nanofibers is disclosed. |
| priorityDate | 2011-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 368.